Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,122 | -18,204 | -12,385 | -6,357 | -15,094 |
| Depreciation Amortization | 150 | 111 | 74 | 35 | 142 |
| Other Working Capital | 199 | -771 | 317 | 1,424 | 671 |
| Other Operating Activity | 1,205 | 807 | 366 | 146 | 349 |
| Operating Cash Flow | $-22,569 | $-18,058 | $-11,629 | $-4,753 | $-13,933 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -141 | -12 | -8 | N/A | -62 |
| Investing Cash Flow | $-141 | $-12 | $-8 | $N/A | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 184 |
| Common Stock Issued | 1,249 | 1,249 | 1,249 | 1,214 | 60,362 |
| Financing Cash Flow | $1,249 | $1,249 | $1,249 | $1,214 | $60,546 |
| Beginning Cash Position | 57,165 | 57,165 | 57,165 | 57,165 | 10,615 |
| End Cash Position | 35,704 | 40,345 | 46,778 | 53,627 | 57,165 |
| Net Cash Flow | $-21,461 | $-16,821 | $-10,388 | $-3,539 | $46,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,569 | -18,058 | -11,629 | -4,753 | -13,933 |
| Capital Expenditure | -141 | -12 | -8 | 0 | -62 |
| Free Cash Flow | -22,710 | -18,069 | -11,636 | -4,753 | -13,995 |